Interactions between calcium and some mylotic agents on depolarized vascular smooth muscle.
D000818:Animals; D002118:Calcium / Q000494:pharmacology*; D004423:Ear / Q000187:drug effects; D066298:In Vitro Techniques; D009130:Muscle, Smooth / Q000187:drug effects*; D009467:Neuromuscular Depolarizing Agents / Q000037:antagonists & inhibitors; D010208:Papaverine / Q000037:antagonists & inhibitors*; D011817:Rabbits; D012402:Rotenone / Q000037:antagonists & inhibitors*; D014662:Vasoconstrictor Agents / Q000494:pharmacology; D014700:Verapamil / Q000037:antagonists & inhibitors
D009467:Neuromuscular Depolarizing Agents; D014662:Vasoconstrictor Agents; D012402:Rotenone; D014700:Verapamil; D010208:Papaverine; D002118:Calcium